Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dobbins

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 12, 2009
Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitusJoshua J Neumiller, Stephen M Setter, Brian J Gates, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|August 20, 2009
Treatment of chorea associated with Huntington's disease: focus on tetrabenazineStephen M Setter, Joshua J Neumiller, Erin K Dobbins, et al.
Nature Communications|August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trialBrittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 12, 2009
Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitusJoshua J Neumiller, Stephen M Setter, Brian J Gates, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|August 20, 2009
Treatment of chorea associated with Huntington's disease: focus on tetrabenazineStephen M Setter, Joshua J Neumiller, Erin K Dobbins, et al.
Nature Communications|August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trialBrittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Pageof 2